Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2010 Jan;108(1):52-7.
doi: 10.1016/j.ijgo.2009.08.022.

Use of prenatal corticosteroids for preterm birth in three Latin American countries

Alicia Aleman Riganti  1 , Maria Luisa Cafferata, Fernando Althabe, Luz Gibbons, Jose Ortiz Segarra, Xochitl Sandoval, José M Belizán
Affiliations
Multicenter Study

Use of prenatal corticosteroids for preterm birth in three Latin American countries

Alicia Aleman Riganti et al. Int J Gynaecol Obstet. 2010 Jan.

Abstract

Objective: To determine the prevalence of the use of prenatal corticosteroids in women who delivered prematurely in 3 Latin American counties and to evaluate the maternal characteristics associated with use.

Methods: A multicenter, prospective, descriptive study was conducted in 4 hospitals in Ecuador, 5 in Uruguay, and 3 in El Salvador between 2004 and 2008. Women who had delivered between 24 and 34 weeks of pregnancy responded to a questionnaire assessing sociodemographic characteristics, obstetric history, prenatal care, women's attitudes to health services and knowledge of preterm risk factors, prenatal corticosteroid administration, and characteristics of the delivery and neonate. The association between the prenatal corticosteroid use and the study variables was evaluated through a logistic regression analysis based on a hierarchical model.

Results: A total of 1062 women who had a preterm birth were included in the study. Prenatal corticosteroid use was 34.8% (95% CI, 29.9%-39.9%) in Ecuador, 54.6% (95% CI, 49.6%-59.6%) in El Salvador, and 71.0% (95% CI, 65.3%-76.2%) in Uruguay. Hospital admission-to-delivery time was associated with the use of prenatal corticosteroids in all 3 countries.

Conclusion: The study revealed a varied pattern of use of prenatal corticosteroids across the 3 countries, and a diversity of influencing factors.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Hierarchical model explaining the relationship between the study variables and use of prenatal corticosteroids
Figure 2
Figure 2
Flow chart showing recruitment process by country.
See this image and copyright information in PMC

References

    1. MacDorman MF, Martin JA, Mathews MS, Hoyert DL. Explaining the 2001-02 Infant Mortality Increase: Data from the linked birth/infant data set. National Vital Statistics Reports. [September 4, 2009]. Available at: http://www.cdc.gov/nchs/data/nvsr/nvsr53/nvsr53_12.pdf. - PubMed
    1. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;50(4):515–25. - PubMed
    1. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;(3):CD004454. - PubMed
    1. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel. JAMA. 1995;273(5):413–8. - PubMed
    1. Antenatal corticosteroids revisited: repeat courses. NIH Consens Statement. 2000;17(2):1–18. - PubMed

Publication types

Substances